Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 6 studies | 19% ± 3% |
Insufficient scRNA-seq data for expression of FNTB at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 1703.09 | 1445 / 1445 | 100% | 6.16 | 183 / 183 |
| uterus | 100% | 1325.72 | 170 / 170 | 100% | 8.20 | 459 / 459 |
| skin | 100% | 2328.39 | 1808 / 1809 | 100% | 14.16 | 472 / 472 |
| brain | 100% | 2459.26 | 2639 / 2642 | 100% | 11.72 | 705 / 705 |
| prostate | 100% | 1572.21 | 245 / 245 | 100% | 7.32 | 501 / 502 |
| ovary | 100% | 1242.29 | 180 / 180 | 100% | 6.20 | 429 / 430 |
| breast | 100% | 1253.69 | 459 / 459 | 99% | 7.68 | 1112 / 1118 |
| kidney | 100% | 1242.83 | 89 / 89 | 99% | 6.67 | 894 / 901 |
| thymus | 100% | 1138.00 | 653 / 653 | 99% | 5.94 | 600 / 605 |
| lung | 99% | 1035.44 | 574 / 578 | 100% | 6.07 | 1152 / 1155 |
| bladder | 100% | 1170.90 | 21 / 21 | 99% | 6.53 | 499 / 504 |
| intestine | 100% | 1097.34 | 966 / 966 | 99% | 5.58 | 521 / 527 |
| adrenal gland | 100% | 1844.57 | 258 / 258 | 97% | 7.99 | 224 / 230 |
| pancreas | 98% | 629.42 | 321 / 328 | 99% | 6.25 | 176 / 178 |
| stomach | 99% | 959.67 | 357 / 359 | 97% | 4.76 | 276 / 286 |
| liver | 100% | 777.61 | 226 / 226 | 90% | 3.60 | 365 / 406 |
| adipose | 100% | 1203.74 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 11.11 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 5.03 | 29 / 29 |
| spleen | 100% | 1003.00 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 7.50 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 10.18 | 1 / 1 |
| muscle | 100% | 1846.68 | 802 / 803 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 1257.84 | 1330 / 1335 | 0% | 0 | 0 / 0 |
| heart | 96% | 1199.94 | 829 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 90% | 918.54 | 833 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006629 | Biological process | lipid metabolic process |
| GO_0018343 | Biological process | protein farnesylation |
| GO_0005965 | Cellular component | protein farnesyltransferase complex |
| GO_0005829 | Cellular component | cytosol |
| GO_0005875 | Cellular component | microtubule associated complex |
| GO_0005515 | Molecular function | protein binding |
| GO_0004660 | Molecular function | protein farnesyltransferase activity |
| GO_0008270 | Molecular function | zinc ion binding |
| Gene name | FNTB |
| Protein name | Protein farnesyltransferase subunit beta (FTase-beta) (EC 2.5.1.58) (CAAX farnesyltransferase subunit beta) (Ras proteins prenyltransferase subunit beta) |
| Synonyms | |
| Description | FUNCTION: Essential subunit of the farnesyltransferase complex. Catalyzes the transfer of a farnesyl moiety from farnesyl diphosphate to a cysteine at the fourth position from the C-terminus of several proteins having the C-terminal sequence Cys-aliphatic-aliphatic-X. . |
| Accessions | P49356 ENST00000246166.3 [P49356-1] |